Moreover, we identified increased M2 macrophage infiltration and downregulation of phagocytic macrophage marker CD209 in the TME of the MAG and DOX combinatorial therapy treated ES xenograft tumors (Fig. 7). The gene discussed is CD209; the disease is Ewing sarcoma.